Caseware UK (AP4) 2024.0.164 2024.0.164 2025-12-312025-12-3112025-01-01No description of principal activityfalse1truetruefalse 14830991 2025-01-01 2025-12-31 14830991 2024-01-01 2024-12-31 14830991 2025-12-31 14830991 2024-12-31 14830991 1 2025-01-01 2025-12-31 14830991 d:Director1 2025-01-01 2025-12-31 14830991 d:Director2 2025-01-01 2025-12-31 14830991 d:RegisteredOffice 2025-01-01 2025-12-31 14830991 c:CurrentFinancialInstruments 2025-12-31 14830991 c:CurrentFinancialInstruments 2024-12-31 14830991 c:CurrentFinancialInstruments c:WithinOneYear 2025-12-31 14830991 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 14830991 c:ShareCapital 2025-12-31 14830991 c:ShareCapital 2024-12-31 14830991 c:RetainedEarningsAccumulatedLosses 2025-12-31 14830991 c:RetainedEarningsAccumulatedLosses 2024-12-31 14830991 d:OrdinaryShareClass1 2025-01-01 2025-12-31 14830991 d:OrdinaryShareClass1 2025-12-31 14830991 d:OrdinaryShareClass1 2024-12-31 14830991 d:FRS102 2025-01-01 2025-12-31 14830991 d:Audited 2025-01-01 2025-12-31 14830991 d:FullAccounts 2025-01-01 2025-12-31 14830991 d:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14830991 d:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14830991 e:PoundSterling 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 14830991 (England and Wales)














MF CLINICAL LIMITED

DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025


 
MF CLINICAL LIMITED
 

 
COMPANY INFORMATION


Directors
K Thoelke 
J Trepanier 




Registered number
14830991



Registered office
Birchin Court
5th Floor

19-25 Birchin Lane

London

United Kingdom

EC3V 9DU




Independent auditors
ZEDRA Audit & Assurance (UK) Limited






 
MF CLINICAL LIMITED
 


CONTENTS



Page
Balance Sheet
 
1
Notes to the Financial Statements
 
2 - 3



 
MF CLINICAL LIMITED
REGISTERED NUMBER:14830991


BALANCE SHEET
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
78,728
104,093

  
78,728
104,093

Creditors: amounts falling due within one year
 5 
(480,750)
(395,795)

Net current liabilities
  
 
 
(402,022)
 
 
(291,702)

Total assets less current liabilities
  
(402,022)
(291,702)

  

Net liabilities
  
(402,022)
(291,702)


Capital and reserves
  

Called up share capital 
 6 
1
1

Profit and loss account
  
(402,023)
(291,703)

  
(402,022)
(291,702)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J Trepanier
Director

Date: 24 September 2026

The notes on pages 2 to 3 form part of these financial statements.

Page 1


 
MF CLINICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. 
The Company’s functional and presentational currency is GBP (£), as that is the primary currency in which the Company transacts.

The following principal accounting policies have been applied:

 
1.2

Going concern

The purpose of the Company is to support the parent company, Paradigm Health, Inc., with its global employee tax obligations. The Company is reliant on the continued support of the parent company in order to remain a going concern.
The Company has received written confirmation from its parent company that it will continue to provide financial support to the Company for a period of at least 12 months from the date of signing these financial statements. Furthermore, the directors have assessed the ability of the parent company to provide this support based upon their cashflow forecasts and have concluded that the parent will have sufficient working capital to provide necessary support. For these reasons, the directors continue to adopt the going concern basis in preparing these financial statements.

 
1.3

Debtors

Short-term debtors are measured at transaction price, less any impairment.

 
1.4

Creditors

Short-term creditors are measured at the transaction price. Amounts owed to group undertakings are intercompany loans measured at cost. These loans are unsecured, interest free and repayable on demand.


2.


Employees

The average monthly number of employees during the year was 1 (2024 - 1).


3.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2025 was unqualified.

The audit report was signed on 25 September 2026 by Adam Wildbore FCCA (Senior Statutory Auditor) on behalf of ZEDRA Audit and Assurance (UK) Limited.

Page 2


 
MF CLINICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

4.


Debtors

2025
2024
£
£


Other debtors
77,915
103,114

Prepayments and accrued income
813
979

78,728
104,093



5.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
-
15,270

Amounts owed to group undertakings
460,780
353,009

Accruals and deferred income
19,970
27,516

480,750
395,795



6.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



1 (2024 - 1) Ordinary share of £1.00
1
1



7.


Controlling party

Paradigm Health, Inc. is the parent company of the smallest group for which consolidated financial statements are drawn up of which the Company is a member. The registered office of the parent company is: 175 S. 3rd Street, Suite 1000, Columbus, OH 43215-5197, United States.


8.


Post balance sheet events

There were no adjusting or non-adjusting events occurring between the end of the reporting period and the date of these financial statements were approved.

 
Page 3